Table 10

Drug Treatment for Pheochromocytoma

Drug Action Indication Advantage Disadvantage
Phenoxybenzamine Noncompetitive, nonselective i-blocker All patients Long duration Efficacious Tachycardia, Hypotension
Phentolamine Competitive i-blocker Hypertensive crisis Rapid onset, I.V. Bolus can cause hypotension
Metoprolol, atenolol ß1-blocker Persistent tachycardia Myocardial ischemia ß1-selective, less likely to increase BP or impair caridac function; I.V. or oral. Hypertension crisis if incomplete i-blockade
Labetalol Combined i- and ß- adrenoceptor blocker Persistent tachycarida Myocardial ischemia I.V. or oral. Combined blockade Hypertensive crisis if insufficient i- blockade
i- methylparatyrosine Tyrosine hydroxylase inhibitor. Reduces catecholamine biosynthesis Cardiomyopathy, Refractory to phenoxybenzamine Reduces catecholamine levels Extrapyramidal side effects, crystalluria,
Captopril ACE inhibitor Heart failure, hypertension Afterload reduction BP control Hypotension when combined with i-blocker
NaCl (IV or tablets) Volume expansion Postural hypotension on i-blocker Optimize volume status before surgery Edema, volume overload

(From: Blumenfeld JD and Vaughan Ed Jr: Hypertensive adrenal disorders, In: Therapy in Nephrology and Hypertension, Brady H and Wilcox CS (Eds.). W.B. Saunders (In Press).

Return to article